Linganisha mbinu
Pitia mbinu ulizochagua bega kwa bega; safu zinazotofautiana zinaangaziwa.
| Uchanganuzi wa Cytometry wa Mtiririko× | Uundaji wa Kimodelia wa Madhara ya Dawa kwa Idadi ya Watu× | |
|---|---|---|
| Nyanja | Famakolojia | Famakolojia |
| Familia | Process / pipeline | Process / pipeline |
| Mwaka wa asili≠ | 1976 | 1992 |
| Mwanzilishi≠ | Leonard Herzenberg | Lewis Sheiner and Stephen Roush |
| Aina≠ | cell analysis and sorting | dose-response modeling |
| Chanzo asilia≠ | Herzenberg, L. A., Parks, D., Sahaf, B., Perez, O., Roederer, M., & Herzenberg, L. A. (2002). The history and future of the fluorescence-activated cell sorter and flow cytometry: a view from Stanford. Clinical Chemistry, 48(10), 1819-1827. DOI ↗ | Dahlström, B., & Nyberg, L. (1993). Population pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics, 24(1), 45-57. link ↗ |
| Majina mbadala | FACS, fluorescence-activated cell sorting, cell analysis | PopPD, population PD, hierarchical PD modeling |
| Zinazohusiana | 3 | 3 |
| Muhtasari≠ | Flow cytometry is a laser-based technology for analyzing and sorting individual cells based on fluorescent markers. Developed by Leonard Herzenberg in the 1970s, flow cytometry enables rapid assessment of cell phenotype, drug effects on cell populations, and therapeutic cell characterization in immunology and hematology. | Population pharmacodynamic (PopPD) modeling integrates pharmacokinetics with individual dose-response relationships across patient populations to characterize drug efficacy and tolerability. Pioneered by Lewis Sheiner and colleagues, PopPD accounts for inter-individual variability in drug effects and enables rational dose optimization and response prediction. |
| ScholarGateSeti ya data ↗ |
|
|